<DOC>
	<DOCNO>NCT00000780</DOCNO>
	<brief_summary>PRIMARY : To identify , characterize , co-enroll HIV-infected adolescent exist future ACTG ( NIH-sponsored ) HIV treatment protocol systematic recurrent assessment eligibility . To assess ability adolescent enrol ACTG 220 adhere ACTG ( NIH-sponsored ) HIV treatment protocol ; define factor influence adolescent 's ability enter adhere study protocol . SECONDARY : To describe nature , stage , progression HIV infection adolescent . Little known HIV-infected adolescent group , result , small number currently enrol ACTG drug study . Creative approach need encourage enrollment HIV-infected adolescent whose socio-demographic profile make access NIH-sponsored research unlikely .</brief_summary>
	<brief_title>A `` Pre-Enrollment '' Protocol HIV-Infected Adolescents</brief_title>
	<detailed_description>Little known HIV-infected adolescent group , result , small number currently enrol ACTG drug study . Creative approach need encourage enrollment HIV-infected adolescent whose socio-demographic profile make access NIH-sponsored research unlikely . At entry every subsequent visit , participant systematically evaluate eligibility willingness enter ACTG ( NIH-sponsored ) HIV treatment protocol menu develop updated Pediatric Adolescent Working Group ACTG . A survey participant attitude , behavior , belief administer updated semiannually . Participants attend clinic visit every 3 month follow minimum 6 month , end study . They receive periodic physical exam , STD gynecologic genitourinary evaluation , HIV symptom assessment related diagnosis , TB evaluation , laboratory test ( hematology immunology ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Participants must meet following criterion : HIV infection . NOT currently enrol ACTG treatment protocol . Exclusion Criteria Coexisting Condition : Participants follow condition exclude : No legal provision consent participate clinical research determine .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2003</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Adolescent Behavior</keyword>
</DOC>